Valentina Angela Marsico

Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer

Roberto Moretto, Chiara Cremolini, Daniele Rossini et al. · The Oncologist · 2016 · 102 citations

Medicine, Oncology, Pharmacology +16

Single-Agent Panitumumab in Frail Elderly Patients With Advanced <i>RAS</i> and <i>BRAF</i> Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New Hope

Filippo Pietrantonio, Chiara Cremolini, Giuseppe Aprile et al. · The Oncologist · 2015 · 50 citations · Full text

Medicine, Oncology, Pharmacology +13

Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study

Roberto Iezzi, Valentina Angela Marsico, Alessandra Guerra et al. · CardioVascular and Interventional Radiology · 2015 · 49 citations

Medicine, Oncology, Pharmacology +17

Anastrozole-related acute hepatitis with autoimmune features: a case report

Alessandro Inno, Michele A. Basso, Fabio Maria Vecchio et al. · BMC Gastroenterology · 2011 · 31 citations · Full text

Life Sciences, Immunology, Pharmacology +17

TRIPLETE: a randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer

Beatrice Borelli, Roberto Moretto, Sara Lonardi et al. · ESMO Open · 2018 · 23 citations · Full text

Medicine, Oncology, Pharmacotherapy +17